Sage Journals: Discover world-class research

Retricted access

Research article

First published 2017-8

Of patents and patent disputes: The TNFα patent files. Part 1: Humira

Ulrich Storz

Human Antibodies

Open access

Review article

First published 2024

The totality of evidence approach in the development of AVT02 (adalimumab),a biosimilar to Humira

Joseph E. McClellan, Sesselja Ómarsdóttir, Nivedita Roy [...]

Sage Open Chronic Disease

Retricted access

Research article

First published 2005-3

Adalimumab (Humira): A Review

Ahmed Hadi

Journal of Psoriasis and Psoriatic Arthritis®

Retricted access

Research article

First published 2011-08

Toxicity of High-Dose Intravitreal Adalimumab (Humira) in the Rabbit

Roberta P.A. Manzano, Gholam A. Peyman, Petros E. Carvounis [...]

Journal of Ocular Pharmacology and Therapeutics

Retricted access

Research article

First published 2013-04

Other Indications Approved for Humira

Biotechnology Law Report

Retricted access

Research article

First published 2012-12

FDA Approves New Indication for Humira

Biotechnology Law Report

Free access

Research article

First published 2016-5

A Systematic Characterization of Aquaporin-9 Expression in Human Normal and Pathological Tissues

Cecilia Lindskog, Anna Asplund, Anca Catrina [...]

Journal of Histochemistry & Cytochemistry

Retricted access

Research article

First published 2017-06

Biosimilar Companies Chipping Away at Humira,but No Death Knells Yet

Lucian C. Chen

Biotechnology Law Report

Retricted access

Research article

First published 2012-06

Supreme Court Upholds Finding That Humira Does Not Infringe

Biotechnology Law Report

Retricted access

Research article

First published 2017-02

AbbVie Hopes to Maintain Humira Exclusivity Through Secondary Patents and Regulatory Barriers to Entry

Christopher M. Holman

Biotechnology Law Report

Search results